Ki-Mo Jang1, Ju-Han Lee, Chan Mi Park, Hae-Ryong Song, Joon Ho Wang. 1. Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Gu, Seoul, 135-710, South Korea, kimo98@hanmail.net.
Abstract
PURPOSE: The aim of this work is to investigate the feasibility of non-autologous transplantation of human mesenchymal stem cells (hMSCs) with or without differentiation for the regeneration of osteochondral defects in rabbits using a biphasic composite construct composed of platelet-rich fibrin glue (PR-FG) and hydroxyapatite. METHODS: After isolation and culture, hMSCs were seeded on biphasic composite constructs (hydroxyapatite + PR-FG) and transplanted into osteochondral defects of adult New Zealand white rabbits. Treatment of individual defects was applied by random assignment to one of five groups: (1) control, defects untreated; (2) hydroxyapatite, defects filled with hydroxyapatite only; (3) hydroxyapatite + PR-FG, defects filled with a composite of hydroxyapatite and PR-FG; (4) hydroxyapatite + PR-FG + undifferentiated hMSCs; and (5) hydroxyapatite + PR-FG + differentiated hMSCs. Rabbits were killed at 4 or 8 weeks post-surgery, at which time osteochondral repair was macroscopically and histologically evaluated and scored using the modified International Cartilage Repair Society scoring system. RESULTS: The group in which defects were seeded with differentiated hMSCs (group 5) showed superior healing of osteochondral defects based on macroscopic and histological observations compared to other groups. Specifically, 8 weeks after implantation, defects were filled with more hyaline-like cartilage and were better integrated with the surrounding native cartilage. The histological scores were significantly better than those of other groups (16.3 at 8 weeks, p < 0.01). CONCLUSION: Xenogeneic transplantation of differentiated hMSCs using a biphasic composite construct effectively repaired osteochondral defect in a rabbit model. Differentiated hMSCs showed superior healing of chondral lesion to undifferentiated hMSCs.
PURPOSE: The aim of this work is to investigate the feasibility of non-autologous transplantation of human mesenchymal stem cells (hMSCs) with or without differentiation for the regeneration of osteochondral defects in rabbits using a biphasic composite construct composed of platelet-rich fibrin glue (PR-FG) and hydroxyapatite. METHODS: After isolation and culture, hMSCs were seeded on biphasic composite constructs (hydroxyapatite + PR-FG) and transplanted into osteochondral defects of adult New Zealand white rabbits. Treatment of individual defects was applied by random assignment to one of five groups: (1) control, defects untreated; (2) hydroxyapatite, defects filled with hydroxyapatite only; (3) hydroxyapatite + PR-FG, defects filled with a composite of hydroxyapatite and PR-FG; (4) hydroxyapatite + PR-FG + undifferentiated hMSCs; and (5) hydroxyapatite + PR-FG + differentiated hMSCs. Rabbits were killed at 4 or 8 weeks post-surgery, at which time osteochondral repair was macroscopically and histologically evaluated and scored using the modified International Cartilage Repair Society scoring system. RESULTS: The group in which defects were seeded with differentiated hMSCs (group 5) showed superior healing of osteochondral defects based on macroscopic and histological observations compared to other groups. Specifically, 8 weeks after implantation, defects were filled with more hyaline-like cartilage and were better integrated with the surrounding native cartilage. The histological scores were significantly better than those of other groups (16.3 at 8 weeks, p < 0.01). CONCLUSION: Xenogeneic transplantation of differentiated hMSCs using a biphasic composite construct effectively repaired osteochondral defect in a rabbit model. Differentiated hMSCs showed superior healing of chondral lesion to undifferentiated hMSCs.
Authors: Matthias Zscharnack; Pierre Hepp; Robert Richter; Thomas Aigner; Ronny Schulz; Jeremy Somerson; Christoph Josten; Augustinus Bader; Bastian Marquass Journal: Am J Sports Med Date: 2010-05-27 Impact factor: 6.202
Authors: Amgad M Haleem; Abdel Aziz El Singergy; Dina Sabry; Hazem M Atta; Laila A Rashed; Constance R Chu; Mohammed T El Shewy; Akram Azzam; Mohammed T Abdel Aziz Journal: Cartilage Date: 2010-10 Impact factor: 4.634
Authors: Scott M Riester; Janet M Denbeigh; Yang Lin; Dakota L Jones; Tristan de Mooij; Eric A Lewallen; Hai Nie; Christopher R Paradise; Darcie J Radel; Amel Dudakovic; Emily T Camilleri; Dirk R Larson; Wenchun Qu; Aaron J Krych; Matthew A Frick; Hee-Jeong Im; Allan B Dietz; Jay Smith; Andre J van Wijnen Journal: Stem Cells Transl Med Date: 2016-10-26 Impact factor: 6.940
Authors: David Pescador; Arturo Ibáñez-Fonseca; Fermín Sánchez-Guijo; Jesús G Briñón; Francisco Javier Arias; Sandra Muntión; Cristina Hernández; Alessandra Girotti; Matilde Alonso; María Consuelo Del Cañizo; José Carlos Rodríguez-Cabello; Juan Francisco Blanco Journal: J Mater Sci Mater Med Date: 2017-06-24 Impact factor: 3.896
Authors: Jason L Guo; Yu Seon Kim; Elysse A Orchard; Jeroen J J P van den Beucken; John A Jansen; Mark E Wong; Antonios G Mikos Journal: Tissue Eng Part C Methods Date: 2020-11-11 Impact factor: 3.056